Ballantyne Therapeutics
Charlotte, US · Founded 2014
Biotech
Founders & leadership
BE
Brian E. DoxtatorDirector
MR
Michael RobertsExecutive Officer, Director
DR
Donald R ReynoldsDirector
SP
Simon PedderDirector
Reported raises · per SEC filings
Form D private placements$565KraisedOct 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.